The now-defunct New York City clinic used its website, social media, newspapers and television commercials to advertise unproven stem cell treatments for several conditions, including urological diseases, cardiac/pulmonary disease, neurological diseases, autoimmune diseases and orthopedic conditions.
The clinic’s website said that stem cells “represent a medical breakthrough in the treatment of many chronic medical conditions,” among other unsubstantiated claims, the New York State Office of the Attorney General said in a Nov. 25 news release.
Patients were charged almost $4,000 out of pocket per treatment, with some paying more than $20,000 for multiple treatments, according to the lawsuit. Most of the procedures involved adipose stem cells derived from the patient’s own fat tissues.
“Consumers place a great deal of trust in healthcare professionals and should receive accurate information when undergoing medical treatments, but Park Avenue Stem Cell and its managing doctor violated that trust in an effort to line their pockets at the expense of patients’ health,” New York Attorney General Letitia James said. “Today’s order makes clear that these deceptive practices will not be tolerated and that bad actors will be held accountable to the fullest extent of the law.”
Dr. Singer did not immediately respond to Becker’s request for comment.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
